Nanoenabled intracellular zinc bursting for efficacious reversal of gefitinib resistance in lung cancer
{{output}}
Following the identification of specific epidermal growth factor receptor (EGFR)-activating mutations, gefitinib, one of the first-generation tyrosine kinase inhibitors (TKIs), has proven efficacious in targeting NSCLC that is driven by specific EGFR-activatin... ...
